Lv3
218 积分 2025-09-22 加入
Potential applications of PFKFB in cancer treatment strategies
1个月前
已完结
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer
1个月前
已完结
Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis
1个月前
已完结
SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
1个月前
已完结
Cancer metabolism: looking forward
1个月前
已完结
Non-small-cell lung cancer
1个月前
已完结
Heterogeneity of glutamine metabolism in acquired-EGFR-TKI-resistant lung cancer
1个月前
已完结
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer
1个月前
已完结
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma
1个月前
已完结
The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells
1个月前
已完结
皖公网安备34019202002308
